Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://oisiygsj157980.59bloggers.com/39393896/trelaglutide-exploring-a-new-therapy-for-chronic-diseases